Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-91.79	55.04	-670.19
Graham Fair Price	-43.12	21.93	38.55
PEG	749.15	-0.07	< 0.005
Price/Book	-2.94	0.57	0.59
Price/Cash Flow	36.35	111.22	81.57
Prices/Earnings	194.50	9.32	-3.17
Price/Sales	1.56	17.68	17.40
Price/FCF	36.35	111.22	81.57
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	29.70	0.71	0.55
Operating Margin	1025.32	0.74	-0.07
ROA	-67.08	< 0.005	-0.02
ROE	-0.05	0.02	-67.04
ROIC	< 0.005	0.01	876.47
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.01	54.38
Dividends QOQ	-1.00	27661.30	2766095.21
EBIT QOQ	-1.10	11.69	966.80
EPS QOQ	-3.82	1.33	-65.32
FCF QOQ	-0.41	-0.29	29.12
Revenue QOQ	0.11	-0.05	-54.31
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	92.63	95.27	2.86
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.44	0.44	0.13
Quick Ratio	0.32	0.34	7.88
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	37.68	37.33	-0.92
Cash	0.76	0.67	-12.10
Capex	-0.14	-0.16	-18.49
Free Cash Flow	0.27	0.19	-29.47
Revenue	1.28	1.21	-5.31
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.32	0.35	11.63
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-376.50	31.37	-91.67
Naive Interpretation	Member

06 - Financial Health · Bad

Rating